JAMA Psychiatry

Article	Citations
Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm?	619
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder	614
Establishment of Best Practices for Evidence for Prediction	400
Internet-Based Cognitive Behavioral Therapy for Depression	394
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	376
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness	338
Prevention of Psychosis	282
Perturbations in Gut Microbiota Composition in Psychiatric Disorders	281
How COVID-19 Affects the Brain	277
Association Between Physical Activity and Risk of Depression	274
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence	244
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19	236
Battling the Modern Behavioral Epidemic of Loneliness	219
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia	208
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	208
From Basic Science to Clinical Application of Polygenic Risk Scores	189
Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis	166
Could Polygenic Risk Scores Be Useful in Psychiatry?	159
Mental Health in the Coronavirus Disease 2019 Emergency—The Italian Response	158
Psychosocial Interventions and Immune System Function	153
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	151
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries	151
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder	150
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	148
Probability of Transition to Psychosis in Individuals at Clinical High Risk	148

Associations Between Prenatal Cannabis Exposure and Childhood Outcomes	147
Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms	144
Telepsychiatry and the Coronavirus Disease 2019 Pandemic—Current and Future Outcomes of the Rapid Virtualization of Psychiatric Care	143
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection	143
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions	142
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder	131
Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression	130
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	130
Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression	120
Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse	120
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders	119
Cognitive Behavioral Treatments for Anxiety in Children With Autism Spectrum Disorder	118
Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 Pandemic	116
The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health	116
The Current Status of Psychedelics in Psychiatry	114
Adjunctive Psychotherapy for Bipolar Disorder	113
Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries	113
Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings	110
Association of Outdoor Artificial Light at Night With Mental Disorders and Sleep Patterns Among US Adolescents	107
Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women	103
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder	102
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia	101
Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic	101
Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders	100
Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell–Derived Cerebral Organoids in Schizophrenia	100
Effect of Zuranolone vs Placebo in Postpartum Depression	100
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	98
Male and Female Physician Suicidality	97
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis	96
Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients	95
Racial Differences in Statewide Suicide Mortality Trends in Maryland During the Coronavirus Disease 2019 (COVID-19) Pandemic	95
Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers	94
Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence	94
Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth	93
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders	92
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure	92
The Genetic Architecture of Depression in Individuals of East Asian Ancestry	89
Joint International Collaboration to Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic	89
Etiology of Autism Spectrum Disorders and Autistic Traits Over Time	87
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses	85
Association of Preeclampsia in Term Births With Neurodevelopmental Disorders in Offspring	83
Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain	83
Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders	82
National Trends in Mental Health Care for US Adolescents	82
Association of Cannabis Use During Adolescence With Neurodevelopment	80
Association of Drug Cues and Craving With Drug Use and Relapse	79
Risk of Subjection to Violence and Perpetration of Violence in Persons With Psychiatric Disorders in Sweden	78
Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia	78
Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder	77
Social Isolation and Loneliness in Older Adults—A Mental Health/Public Health Challenge	76

All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids	76
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity	75
Suicide Prevention in the COVID-19 Era	73
Applying Causal Inference Methods in Psychiatric Epidemiology	73
Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis	72
Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons	71
Identification of Suicide Attempt Risk Factors in a National US Survey Using Machine Learning	71
Prediction, Not Association, Paves the Road to Precision Medicine	70
Association of Mental Disorder in Childhood and Adolescence With Subsequent Educational Achievement	70
Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms	70
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features	69
Effectiveness of Task-Shifted Trauma-Focused Cognitive Behavioral Therapy for Children Who Experienced Parental Death and Posttraumatic Stress in Kenya and Tanzania	69
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level	69
Overdose-Related Cardiac Arrests Observed by Emergency Medical Services During the US COVID-19 Epidemic	68
Association of US Nurse and Physician Occupation With Risk of Suicide	68
Efficacy and Safety of Lumateperone for Treatment of Schizophrenia	68
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019	66
Emergency Department Encounters Among Youth With Suicidal Thoughts or Behaviors During the COVID-19 Pandemic	66
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia	64
Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment	64
Association Between Ambient Heat and Risk of Emergency Department Visits for Mental Health Among US Adults, 2010 to 2019	64
Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety	64
Contingency Management for Patients Receiving Medication for Opioid Use Disorder	63
Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children	62
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic	62
Stratified Care vs Stepped Care for Depression	61
Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities	61
Association of Screen Time With Internalizing and Externalizing Behavior Problems in Children 12 Years or Younger	61
Associations Between Depression, Arterial Stiffness, and Metabolic Syndrome Among Adults in the UK Biobank Population Study	60
Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?	57
Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia	56
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence	56
Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects	55
Age-Specific Prevalence and Incidence of Dementia Diagnoses Among Older US Adults With Schizophrenia	55
Genetic Associations Between Childhood Psychopathology and Adult Depression and Associated Traits in 42 998 Individuals	55
Association of Antihypertensive Drug Target Genes With Psychiatric Disorders	55
Association of Hypothyroidism and Clinical Depression	54
Multimodal Categorical and Dimensional Approaches to Understanding Threat Conditioning and Its Extinction in Individuals With Anxiety Disorders	54
Findings From World Mental Health Surveys of the Perceived Helpfulness of Treatment for Patients With Major Depressive Disorder	53
Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder	52
Computational Mechanisms of Effort and Reward Decisions in Patients With Depression and Their Association With Relapse After Antidepressant Discontinuation	52
Association of Schizophrenia Spectrum Disorders and Violence Perpetration in Adults and Adolescents From 15 Countries	51
Outcomes of Randomized Clinical Trials of Interventions to Enhance Social, Emotional, and Spiritual Components of Wisdom	51
A Development Pathway Towards Precision Mental Health Care	50
Preaddiction—A Missing Concept for Treating Substance Use Disorders	50
Meeting Maternal Mental Health Needs During the COVID-19 Pandemic	50
Reinforcement Learning in Patients With Mood and Anxiety Disorders vs Control Individuals	50
Trends in Suicidality 1 Year Before and After Birth Among Commercially Insured Childbearing Individuals in the United States, 2006-2017	50
Management of Patients With Severe Mental Illness During the Coronavirus Disease 2019 Pandemic	50
Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment	49
Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness	49
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	49
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People	47
Trends in the Incidence and Lethality of Suicidal Acts in the United States, 2006 to 2015	47
Racial/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic	47
Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression	47
Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US	47
Cost-effectiveness of Treatments for Opioid Use Disorder	47
Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder	47
Suicide Prevention Research Priorities in Health Care	47
Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder	46
Association of Racial Discrimination With Neural Response to Threat in Black Women in the US Exposed to Trauma	46
Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression	46
Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function	46
Racial/Ethnic Disparities in the Performance of Prediction Models for Death by Suicide After Mental Health Visits	46
Efficacy of Yoga vs Cognitive Behavioral Therapy vs Stress Education for the Treatment of Generalized Anxiety Disorder	46
Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition	46
Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder	46
Longitudinal Associations of Mental Disorders With Dementia	46
Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population	46
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia	45
Can Sophisticated Study Designs With Regression Analyses of Observational Data Provide Causal Inferences?	45
Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness	45
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	45
Reinforcement Learning Disruptions in Individuals With Depression and Sensitivity to Symptom Change Following Cognitive Behavioral Therapy	44
Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non–COVID-19 Illness	44
Treatment of Patients With Anorexia Nervosa in the US—A Crisis in Care	44
Prevalence and Risk Factors Associated With Attention-Deficit/Hyperactivity Disorder Among US Black Individuals	43
Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails	43
Implementation and Effectiveness of Nonspecialist-Delivered Interventions for Perinatal Mental Health in High-Income Countries	43

Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis	42
Religious Service Attendance and Deaths Related to Drugs, Alcohol, and Suicide Among US Health Care Professionals	42
Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis	42
Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark	42
Associations Between Schizophrenia Polygenic Liability, Symptom Dimensions, and Cognitive Ability in Schizophrenia	41
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode	41
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	41
Family Genetic Risk Scores and the Genetic Architecture of Major Affective and Psychotic Disorders in a Swedish National Sample	41
The Healthy Brain and Child Development Study—Shedding Light on Opioid Exposure, COVID-19, and Health Disparities	41
Longitudinal Trends in Childhood Insulin Levels and Body Mass Index and Associations With Risks of Psychosis and Depression in Young Adults	41
Prevalence and Trends in Suicidal Behavior Among US Military Veterans During the COVID-19 Pandemic	41
Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders	40
Use of Medications for Alcohol Use Disorder in the US	40
Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression	40
Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder	40
The Loss of Social Connectedness as a Major Contributor to Physician Burnout	40
An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings	40
The Differential Outcomes of Coronavirus Disease 2019 in Low- and Middle-Income Countries vs High-Income Countries	39
Race as a Social Construct in Psychiatry Research and Practice	39
Effectiveness of Predominantly Group Schema Therapy and Combined Individual and Group Schema Therapy for Borderline Personality Disorder	39
Preparing for the Bursting of the Psychedelic Hype Bubble	39
Going Upstream to Advance Psychosis Prevention and Improve Public Health	39
Current Epidemiological Trends in Firearm Mortality in the United States	39
Why Deaths of Despair Are Increasing in the US and Not Other Industrial Nations—Insights From Neuroscience and Anthropology	39
Risk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia	39
Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs	39
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	39
Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US	39
Association of Recent Stressful Life Events With Mental and Physical Health in the Context of Genomic and Exposomic Liability for Schizophrenia	39
Association of Nondiscrimination Policies With Mental Health Among Gender Minority Individuals	38
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	38
Assessment of Neurobiological Mechanisms of Cortical Thinning During Childhood and Adolescence and Their Implications for Psychiatric Disorders	38
Association of Multigenerational Family History of Depression With Lifetime Depressive and Other Psychiatric Disorders in Children	38
Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients	37
Removing the Reliability Bottleneck in Functional Magnetic Resonance Imaging Research to Achieve Clinical Utility	37
Association of High Traditional Masculinity and Risk of Suicide Death	37
Computational Markers of Risky Decision-making for Identification of Temporal Windows of Vulnerability to Opioid Use in a Real-world Clinical Setting	37
Association of Intrinsic Brain Architecture With Changes in Attentional and Mood Symptoms During Development	37
Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder	37
Association of Social Determinants of Health and Vaccinations With Child Mental Health During the COVID-19 Pandemic in the US	37
Driving Performance and Cannabis Users’ Perception of Safety	37
Mortality Associated With Mental Disorders and Comorbid General Medical Conditions	36
Mood Homeostasis Before and During the Coronavirus Disease 2019 (COVID-19) Lockdown Among Students in the Netherlands	36
Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US	36
Novel Risk Loci Associated With Genetic Risk for Bipolar Disorder Among Han Chinese Individuals	35
Association of Youth Depression With Subsequent Somatic Diseases and Premature Death	35
Association of History of Psychopathology With Accelerated Aging at Midlife	35
A Framework for Advancing Precision Medicine in Clinical Trials for Mental Disorders	34
Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals	34
Lithium Treatment in the Prevention of Repeat Suicide-Related Outcomes in Veterans With Major Depression or Bipolar Disorder	33
Changes Over Time in the Differential Mortality Gap in Individuals With Mental Disorders	33
Effectiveness of a Guided Web-Based Self-help Intervention to Prevent Depression in Patients With Persistent Back Pain	33
Discriminating Heterogeneous Trajectories of Resilience and Depression After Major Life Stressors Using Polygenic Scores	33
Effect of Shamiri Layperson-Provided Intervention vs Study Skills Control Intervention for Depression and Anxiety Symptoms in Adolescents in Kenya	33
Risk of Early-Onset Depression Associated With Polygenic Liability, Parental Psychiatric History, and Socioeconomic Status	33
Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19	32
Changes and Inequities in Adult Mental Health–Related Emergency Department Visits During the COVID-19 Pandemic in the US	32
National Trends of Mental Health Care Among US Adults Who Attempted Suicide in the Past 12 Months	32
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span	32
Continuation of Antidepressants vs Sequential Psychological Interventions to Prevent Relapse in Depression	32
Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape	32
Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated With SARS-CoV-2 Infection	32
Time to Support Extensive Implementation of Shared Decision Making in Psychiatry	32
Socioeconomic Indicators of Treatment Prognosis for Adults With Depression	31
Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count	31
Psychiatry in Times of the Coronavirus Disease 2019 (COVID-19) Pandemic	31
Structural Magnetic Resonance Imaging All Over Again	31
Effect of Online 1-Day Cognitive Behavioral Therapy–Based Workshops Plus Usual Care vs Usual Care Alone for Postpartum Depression	31
Pragmatic Precision Psychiatry—A New Direction for Optimizing Treatment Selection	31
Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia	31
Neurodevelopmental Disorders Among Publicly or Privately Insured Children in the United States	31
Genetically Proxied Diurnal Preference, Sleep Timing, and Risk of Major Depressive Disorder	31
Clinical Genetic Testing in Autism Spectrum Disorder in a Large Community-Based Population Sample	31
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth	31
The Rapid Rise in Investment in Psychedelics—Cart Before the Horse	30
Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections	30
Association of Borderline Personality Disorder Criteria With Suicide Attempts	30
Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia	29
Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial Prefrontal Cortex Activity During Peripheral Adrenergic Stimulation	29
Comparison of Teleintegrated Care and Telereferral Care for Treating Complex Psychiatric Disorders in Primary Care	29
Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems	28
Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data	28
Association of Early-Life Mental Health With Biomarkers in Midlife and Premature Mortality	28
Association of Magnetoencephalographically Measured High-Frequency Oscillations in Visual Cortex With Circuit Dysfunctions in Local and Large-scale Networks During Emerging Psychosis	28
The Origin of Our Modern Concept of Depression—The History of Melancholia From 1780-1880	27
Tapering Antipsychotic Treatment	27
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	27
Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms	26
Mood Homeostasis, Low Mood, and History of Depression in 2 Large Population Samples	26
Association of Insulin Resistance With Depression Severity and Remission Status	26
Individual Differences in Response to Antidepressants	26
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19	26
Individual Differences in Response to Antidepressants	25
Social Determinants of Mental Health	25
Association of Childhood Adversities With Suicide Ideation and Attempts in Puerto Rican Young Adults	25